Phage Therapy: Past; Present and Future
Historically, the first observation of a transmissible lytic agent that is specifically active against a bacterium (Bacillus anthracis) was by a Russian microbiologist Nikolay Gamaleya in 1898. At that time, however, it was too early to make a connection to another discovery made by Dmitri Ivanovsky...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2017 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (392 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phage therapy : : current research and applications / / edited by Jan Borysowski, Department of Clinical Immunology, The Medical University of Warsaw, Warsaw, Poland, Ryszard Miedzybrodzki and Andrzej Gorski, Department of Clinical Immunology, The Medical University of Warsaw, Warsaw, and Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocaw, Poland.
Published: ([2014]) -
Hurdles for Phage Therapy (PT) to Become a Reality
by: Brüssow, Harald
Published: (2019) -
Biotechnological Applications of Phage and Phage-Derived Proteins
by: Santos, Sílvio.
Published: (2019) -
Phage nanobiotechnology / edited by Valery A. Petrenko, George P. Smith.
Published: (2011.) - Past, Present, and Future